The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 27, 2024
Filed:
May. 21, 2019
Applicants:
United States Government As Represented BY the Department of Veterans Affairs, Washington, DC (US);
University of South Florida, Tampa, FL (US);
Inventors:
Assignees:
UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS, Washington, DC (US);
UNIVERSITY OF SOUTH FLORIDA, Tampa, FL (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 9/127 (2006.01); A61K 47/36 (2006.01); C12N 15/113 (2010.01); A61K 47/54 (2017.01); A61K 47/69 (2017.01); A61K 39/12 (2006.01); A61K 45/06 (2006.01); B82Y 5/00 (2011.01);
U.S. Cl.
CPC ...
A61K 47/544 (2017.08); A61K 39/12 (2013.01); A61K 45/06 (2013.01); A61K 47/6939 (2017.08); B82Y 5/00 (2013.01); C12N 15/1131 (2013.01); C12N 2310/122 (2013.01); C12N 2310/14 (2013.01);
Abstract
This invention provides for a RSV-targeted nanoparticle PMN (RTPMN), combining HR2D anti-fusion peptide, and plasmid encoded siRNA against RSV-NS1 and/or RSV-P gene as a safe, effective and inexpensive anti-RSV prophylaxis and/or therapy.